Dr. Srivastava is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
FDA White Oak Campus
10903 New Hampshire Ave
Silver Spring, MD 20993
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2010 - 2014
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2007 - 2010
- University of Texas, School of Public Health- MD Anderson Cancer CenterMSPH, Public Health- Epidemiology, GPA 4.0, 2005 - 2007
- All India Institute of Medical SciencesClass of 2004
Certifications & Licensure
- CO State Medical License 2013 - 2025
- MN State Medical License 2010 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- American Board of HematologyHematology
- American Board of Medical OncologyMedical Oncology
Publications & Presentations
PubMed
- 44 citationsProspective Multicenter Study of the Impact of Oncotype DX Colon Cancer Assay Results on Treatment Recommendations in Stage II Colon Cancer PatientsGeetika Srivastava, Lindsay A. Renfro, Robert J. Behrens, Margarita Lopatin, Calvin Chao
The Oncologist. 2014-05-01 - 6 citationsLong-term response to lenalidomide in patients with newly diagnosed multiple myelomaTaxiarchis Kourelis, Shaji Kumar, Geetika Srivastava, Morie A. Gertz, Martha Q. Lacy
Leukemia. 2014-02-01 - 4 citationsLong-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapyTaxiarchis Kourelis, Shaji Kumar, Geetika Srivastava, Morie A. Gertz, Martha Q. Lacy
American Journal of Hematology. 2014-03-01
Journal Articles
- Prospective evaluation of a 12-gene assay on treatment recommendations in stage 2 colon cancer patientsGeetika Srivastava, Lindsay Anne Renfro, Robert J. Behrens, Margarita Lopatin, Calvin Chao, Gamini S. Soori, Shaker R. Dakhil, Rex Bradford Mowat, J. Phillip Kuebler, ..., Oncologist, 2014
- Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma.Kourelis TV, Kumar SK, Srivastava G, Gertz MA, Lacy MQ, Buadi FK, Kyle RA, Dispenzieri A., Leukemia, 2014
- Real-world comparative economics of a 12-gene assay for prognosis in stage II colon cancerSteven R. Alberts, Tiffany Yu, Robert J. Behrens, Lindsay Anne Renfro, Geetika Srivastava,Gamini S. Soori, Shaker R. Dakhil, Rex Bradford Mowat, J. Phillip Kuebler, Ge..., Oncologist, 2014
- Join now to see all
Press Mentions
- Colorado Springs Top Doctors 2018October 9th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: